Abstract
In a group of 31 patients a port-a-cath-system for intraperitoneal chemotherapy was installed. From 23 evaluable patients 9 showed a tumor remission, but only 1 was a patient with gastrointestinal carcinoma. All others were patients with ovarial carcinoma. The median survival rate of all patients was 9 months after implantation of the intraperitoneal catheter. 50% of all patients with gastrointestinal carcinoma died within the first 6 months, only 1 of 11 patients with ovarial carcinoma died in this period.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carboplatin
-
Catheters, Indwelling
-
Cisplatin / administration & dosage
-
Critical Care*
-
Drug Evaluation
-
Female
-
Fluorouracil / administration & dosage*
-
Follow-Up Studies
-
Gastrointestinal Neoplasms / drug therapy*
-
Humans
-
Male
-
Middle Aged
-
Organoplatinum Compounds / administration & dosage
-
Ovarian Neoplasms / drug therapy*
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / secondary*
-
Retrospective Studies
Substances
-
Organoplatinum Compounds
-
Carboplatin
-
Cisplatin
-
Fluorouracil